Patents by Inventor Marie-Luise Lubos

Marie-Luise Lubos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy
    Patent number: 11213575
    Abstract: The present invention relates to cell-penetrating effector proteins of type III secretion system (T3SS)-containing bacteria of the genus Salmonella or Shigella and variants, fragments and immunomodulatory domains thereof, for use in immunotherapy. The present invention further relates to cell-penetrating effector proteins of type III secretion system (T3SS)-containing bacteria of the genus Salmonella or Shigella and variants, fragments and immunomodulatory domains thereof, for delivering cargo molecules into eukaryotic cells.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: January 4, 2022
    Assignee: WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER
    Inventors: Marie-Luise Lubos, Alexander Schmidt, Christian Rueter
  • CELL-PENETRATING BACTERIAL E3-UBIQITIN-LIGASES FOR USE IN IMMUNOTHERAPY
    Publication number: 20200038493
    Abstract: The present invention relates to cell-penetrating effector proteins of type III secretion system (T3SS)-containing bacteria of the genus Salmonella or Shigella and variants, fragments and immunomodulatory domains thereof, for use in immunotherapy. The present invention further relates to cell-penetrating effector proteins of type III secretion system (T3SS)-containing bacteria of the genus Salmonella or Shigella and variants, fragments and immunomodulatory domains thereof, for delivering cargo molecules into eukaryotic cells.
    Type: Application
    Filed: August 9, 2019
    Publication date: February 6, 2020
    Applicant: WESTFÃLISCHE WILHELMS-UNIVERSITÃT MÜNSTER
    Inventors: Marie-Luise Lubos, Alexander Schmidt, Christian Rueter
  • Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy
    Patent number: 10406215
    Abstract: The present invention relates to cell-penetrating effector proteins of type III secretion system (T3SS)-containing bacteria of the genus Salmonella or Shigella and variants, fragments and immunomodulatory domains thereof, for use in immunotherapy. The present invention further relates to cell-penetrating effector proteins of type III secretion system (T3SS)-containing bacteria of the genus Salmonella or Shigella and variants, fragments and immunomodulatory domains thereof, for delivering cargo molecules into eukaryotic cells.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: September 10, 2019
    Assignee: WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER
    Inventors: Marie-Luise Lubos, Alexander Schmidt, Christian Rueter
  • CELL-PENETRATING BACTERIAL E3-UBIQITIN-LIGASES FOR USE IN IMMUNOTHERAPY
    Publication number: 20160206713
    Abstract: The present invention relates to cell-penetrating effector proteins of type III secretion system (T3SS)-containing bacteria of the genus Salmonella or Shigella and variants, fragments and immunmodulatory domains thereof, for use in immunotherapy. The present invention further relates to cell-penetrating effector proteins of type III secretion system (T3SS)-containing bacteria of the genus Salmonella or Shigella and variants, fragments and immunmodulatory domains thereof, for delivering cargo molecules into eukaryotic cells.
    Type: Application
    Filed: September 22, 2014
    Publication date: July 21, 2016
    Inventors: Marie-Luise Lubos, Alexander Schmidt, Christian Rueter